Medication

Merck sells stake in vaccine developer Moderna

Britain presses on with AstraZeneca vaccine amid questions over trial data

AstraZeneca likely to run new global trial of its COVID-19 vaccine, CEO says

AstraZeneca says its COVID-19 ‘vaccine for the world’ can be 90% effective

Pfizer applies for U.S. emergency use for COVID-19 vaccine

Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization

Amazon Pharmacy launches in several U.S. states as online giant takes on established drug retailers

Pharmaceutical industry offers Ottawa $1-billion to scrap pending drug pricing rules, documents show

The Globe’s stars and dogs for the week

Pfizer CEO sold $5.6-million of stock on day of COVID-19 vaccine update

BioNTech to price COVID-19 vaccine below ‘typical market rates,’ differentiate between regions

Cardinal Health and AmerisourceBergen book billions in costs related to opioid lawsuits

AstraZeneca pushes back delivery of COVID-19 vaccine doses to U.K. as it awaits trial data

Anti-psychotics use in B.C. care homes rising, report says

Johnson & Johnson fails to overturn $2.12-billion baby powder verdict, plans U.S. Supreme Court appeal

McKesson says cost of opioid settlements could reach $21-billion

Bausch Health says COVID-19 cut third-quarter revenue by $150-million

Britain starts accelerated review for AstraZeneca’s potential COVID-19 vaccine

Gilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short

Pfizer beats earnings expectations as it makes progress on potential COVID-19 vaccine

Germany’s Bayer to buy U.S. gene therapy specialist AskBio

New York University to strip Sackler name from its Langone Medical Center following Purdue Pharma deal

Eli Lilly to continue other COVID-19 antibody drug trials after U.S. pauses one on safety concerns

Johnson & Johnson hikes profit forecast, but pause in COVID-19 vaccine trial weighs on shares

Johnson & Johnson to pay about US$100-million to settle more than 1,000 talc lawsuits: report

Bristol Myers buying heart drug developer MyoKardia for about US$13-billion

U.S. FDA pauses Inovio’s coronavirus vaccine trial plan

Johnson & Johnson kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

Johnson & Johnson facing insurance fraud charges in New York over opioid claims

B.C. moves to dramatically increase access to safe alternatives to illicit drugs

Eli Lilly says its antibody reduces need for hospitalization in moderate COVID-19 patients

Bayer settles thousands of U.S. Roundup cases with trial attorneys

Eli Lilly says its arthritis drug helps accelerate recovery in COVID-19 patients treated with remdesivir